Obesity: A Persistent Puzzle-Unveiling Past Missteps and Future Promise in Drug Discovery

Since obesity is a chronic, multifaceted, and heterogeneous disease influenced by genetic, biological, and environmental factors, it is imperative to approach obesity with an included and complete treatment strategy. Obesity is one of the resulting causes of morbidity and mortality worldwide, and its incidence is increasing globally. Despite significant advancements in the treatment of obesity-related conditions such as high blood pressure, type 2 diabetes, and high cholesterol, treating obesity itself remains a challenging undertaking. Many antiobesity medications (AOMs) don't work as prescribed, leading to insufficient weight loss and safety concerns. This review investigates the evolution of AOM, highlighting past successes and failings to shed light on contemporary problems. Recent advances, particularly in understanding the molecular dialogue between the gut and brain, offer prospective avenues for the next generation of AOMs. These might hold the key to safely and effectively accomplishing substantial, long-term weight loss

Authors

Institutions

Publication Details

Journal
Kerbala journal of pharmaceutical sciences.
Published
2025-07-19
DOI
https://doi.org/10.62472/kjps.v15.i25.149-174
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Obesity: A Persistent Puzzle-Unveiling Past Missteps and Future Promise in Drug Discovery

Sura L. Alkhafaji, Mohammed Fanokh Al-Owaidi
Kerbala journal of pharmaceutical sciences.
Pharmacology and Obesity Treatment
article

Obesity: A Persistent Puzzle-Unveiling Past Missteps and Future Promise in Drug Discovery

Sura L. Alkhafaji, Mohammed Fanokh Al-Owaidi
article en

Abstract

Since obesity is a chronic, multifaceted, and heterogeneous disease influenced by genetic, biological, and environmental factors, it is imperative to approach obesity with an included and complete treatment strategy. Obesity is one of the resulting causes of morbidity and mortality worldwide, and its incidence is increasing globally. Despite significant advancements in the treatment of obesity-related conditions such as high blood pressure, type 2 diabetes, and high cholesterol, treating obesity itself remains a challenging undertaking. Many antiobesity medications (AOMs) don't work as prescribed, leading to insufficient weight loss and safety concerns. This review investigates the evolution of AOM, highlighting past successes and failings to shed light on contemporary problems. Recent advances, particularly in understanding the molecular dialogue between the gut and brain, offer prospective avenues for the next generation of AOMs. These might hold the key to safely and effectively accomplishing substantial, long-term weight loss

Kerbala journal of pharmaceutical sciences.Vol. 15(25)
University of Kerbala (IQ)
Good health and well-being
Openalex Percentile: Top 78%
Pharmacology and Obesity Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Obesity: A Persistent Puzzle-Unveiling Past Missteps and Future Promise in Drug Discovery — Sura L. Alkhafaji, Mohammed Fanokh Al-Owaidi · Kerbala journal of pharmaceutical sciences. (2025) | TGRS Research Map | TGRS